{"entity":{"type":"insider","cik":"0001841401","url":"/insider/0001841401","json_url":"/insider/0001841401.json","name":"Wahl Bryan","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":17,"n_filings":9,"first":"2022-12-01","last":"2026-03-19","span_basis":"filed_date"},"name_variants":[{"name":"Wahl Bryan","source":"filing","n_filings":9,"first_seen":"2022-12-01","last_seen":"2026-03-19"}],"transactions":[{"id":5753552,"accession":"0001841401-26-000007","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001841401-26-000007","line_url":"/filing/0001841401-26-000007#line-3","is_derivative":false,"issuer_cik":"0001819790","issuer_name":"Tarsus Pharmaceuticals, Inc.","issuer_ticker":"TARS","issuer_name_source":null,"issuer_url":"/issuer/0001819790","owner_cik":"0001841401","owner_name":"Wahl Bryan","owner_display_name":"Wahl Bryan","owner_url":"/insider/0001841401","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4231.0,"shares_display":"4,231","price_per_share":67.0,"price_display":"67.00","price_state":"stated","total_value":283477.0,"total_display":"283,477.00","total_whole":"283,477","shares_owned_after":63959.0,"shares_owned_after_display":"63,959","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-19","filed_date":"2026-03-19","scope":"insider"},{"id":5753550,"accession":"0001841401-26-000007","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001841401-26-000007","line_url":"/filing/0001841401-26-000007#line-2","is_derivative":false,"issuer_cik":"0001819790","issuer_name":"Tarsus Pharmaceuticals, Inc.","issuer_ticker":"TARS","issuer_name_source":null,"issuer_url":"/issuer/0001819790","owner_cik":"0001841401","owner_name":"Wahl Bryan","owner_display_name":"Wahl Bryan","owner_url":"/insider/0001841401","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4125.0,"shares_display":"4,125","price_per_share":68.71,"price_display":"68.71","price_state":"stated","total_value":283428.75,"total_display":"283,428.75","total_whole":"283,429","shares_owned_after":68190.0,"shares_owned_after_display":"68,190","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-18","filed_date":"2026-03-19","scope":"insider"},{"id":5753548,"accession":"0001841401-26-000007","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001841401-26-000007","line_url":"/filing/0001841401-26-000007#line-1","is_derivative":false,"issuer_cik":"0001819790","issuer_name":"Tarsus Pharmaceuticals, Inc.","issuer_ticker":"TARS","issuer_name_source":null,"issuer_url":"/issuer/0001819790","owner_cik":"0001841401","owner_name":"Wahl Bryan","owner_display_name":"Wahl Bryan","owner_url":"/insider/0001841401","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4084.0,"shares_display":"4,084","price_per_share":69.42,"price_display":"69.42","price_state":"stated","total_value":283511.28,"total_display":"283,511.28","total_whole":"283,511","shares_owned_after":72315.0,"shares_owned_after_display":"72,315","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-17","filed_date":"2026-03-19","scope":"insider"},{"id":5178712,"accession":"0001819790-25-000057","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001819790-25-000057","line_url":"/filing/0001819790-25-000057#line-3","is_derivative":false,"issuer_cik":"0001819790","issuer_name":"Tarsus Pharmaceuticals, Inc.","issuer_ticker":"TARS","issuer_name_source":null,"issuer_url":"/issuer/0001819790","owner_cik":"0001841401","owner_name":"Wahl Bryan","owner_display_name":"Wahl Bryan","owner_url":"/insider/0001841401","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3084.0,"shares_display":"3,084","price_per_share":50.11,"price_display":"50.11","price_state":"stated","total_value":154539.24,"total_display":"154,539.24","total_whole":"154,539","shares_owned_after":51712.0,"shares_owned_after_display":"51,712","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-20","filed_date":"2025-03-20","scope":"insider"},{"id":5178703,"accession":"0001819790-25-000057","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001819790-25-000057","line_url":"/filing/0001819790-25-000057#line-2","is_derivative":false,"issuer_cik":"0001819790","issuer_name":"Tarsus Pharmaceuticals, Inc.","issuer_ticker":"TARS","issuer_name_source":null,"issuer_url":"/issuer/0001819790","owner_cik":"0001841401","owner_name":"Wahl Bryan","owner_display_name":"Wahl Bryan","owner_url":"/insider/0001841401","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3261.0,"shares_display":"3,261","price_per_share":47.4,"price_display":"47.40","price_state":"stated","total_value":154571.4,"total_display":"154,571.40","total_whole":"154,571","shares_owned_after":54796.0,"shares_owned_after_display":"54,796","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-19","filed_date":"2025-03-20","scope":"insider"},{"id":5178696,"accession":"0001819790-25-000057","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001819790-25-000057","line_url":"/filing/0001819790-25-000057#line-1","is_derivative":false,"issuer_cik":"0001819790","issuer_name":"Tarsus Pharmaceuticals, Inc.","issuer_ticker":"TARS","issuer_name_source":null,"issuer_url":"/issuer/0001819790","owner_cik":"0001841401","owner_name":"Wahl Bryan","owner_display_name":"Wahl Bryan","owner_url":"/insider/0001841401","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3341.0,"shares_display":"3,341","price_per_share":46.29,"price_display":"46.29","price_state":"stated","total_value":154654.89,"total_display":"154,654.89","total_whole":"154,655","shares_owned_after":58057.0,"shares_owned_after_display":"58,057","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-18","filed_date":"2025-03-20","scope":"insider"},{"id":2196688,"accession":"0001819790-24-000046","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001819790-24-000046","line_url":"/filing/0001819790-24-000046#line-2","is_derivative":false,"issuer_cik":"0001819790","issuer_name":"Tarsus Pharmaceuticals, Inc.","issuer_ticker":"TARS","issuer_name_source":null,"issuer_url":"/issuer/0001819790","owner_cik":"0001841401","owner_name":"Wahl Bryan","owner_display_name":"Wahl Bryan","owner_url":"/insider/0001841401","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4436.0,"shares_display":"4,436","price_per_share":30.6,"price_display":"30.60","price_state":"stated","total_value":135741.6,"total_display":"135,741.60","total_whole":"135,742","shares_owned_after":40951.0,"shares_owned_after_display":"40,951","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-18","filed_date":"2024-03-19","scope":"insider"},{"id":8570422,"accession":"0001841401-23-000007","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001841401-23-000007","line_url":"/filing/0001841401-23-000007#line-2","is_derivative":false,"issuer_cik":"0001819790","issuer_name":"Tarsus Pharmaceuticals, Inc.","issuer_ticker":"TARS","issuer_name_source":null,"issuer_url":"/issuer/0001819790","owner_cik":"0001841401","owner_name":"Wahl Bryan","owner_display_name":"Wahl Bryan","owner_url":"/insider/0001841401","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8356.0,"shares_display":"8,356","price_per_share":16.31,"price_display":"16.31","price_state":"stated","total_value":136286.36,"total_display":"136,286.36","total_whole":"136,286","shares_owned_after":31966.0,"shares_owned_after_display":"31,966","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-30","filed_date":"2023-12-01","scope":"insider"},{"id":8212562,"accession":"0001841401-23-000004","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001841401-23-000004","line_url":"/filing/0001841401-23-000004#line-3","is_derivative":false,"issuer_cik":"0001819790","issuer_name":"Tarsus Pharmaceuticals, Inc.","issuer_ticker":"TARS","issuer_name_source":null,"issuer_url":"/issuer/0001819790","owner_cik":"0001841401","owner_name":"Wahl Bryan","owner_display_name":"Wahl Bryan","owner_url":"/insider/0001841401","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":371.0,"shares_display":"371","price_per_share":12.15,"price_display":"12.15","price_state":"stated","total_value":4507.65,"total_display":"4,507.65","total_whole":"4,508","shares_owned_after":16402.0,"shares_owned_after_display":"16,402","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-23","filed_date":"2023-03-23","scope":"insider"},{"id":8212561,"accession":"0001841401-23-000004","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001841401-23-000004","line_url":"/filing/0001841401-23-000004#line-2","is_derivative":false,"issuer_cik":"0001819790","issuer_name":"Tarsus Pharmaceuticals, Inc.","issuer_ticker":"TARS","issuer_name_source":null,"issuer_url":"/issuer/0001819790","owner_cik":"0001841401","owner_name":"Wahl Bryan","owner_display_name":"Wahl Bryan","owner_url":"/insider/0001841401","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":357.0,"shares_display":"357","price_per_share":12.64,"price_display":"12.64","price_state":"stated","total_value":4512.48,"total_display":"4,512.48","total_whole":"4,512","shares_owned_after":16773.0,"shares_owned_after_display":"16,773","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-22","filed_date":"2023-03-23","scope":"insider"},{"id":8212560,"accession":"0001841401-23-000004","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001841401-23-000004","line_url":"/filing/0001841401-23-000004#line-1","is_derivative":false,"issuer_cik":"0001819790","issuer_name":"Tarsus Pharmaceuticals, Inc.","issuer_ticker":"TARS","issuer_name_source":null,"issuer_url":"/issuer/0001819790","owner_cik":"0001841401","owner_name":"Wahl Bryan","owner_display_name":"Wahl Bryan","owner_url":"/insider/0001841401","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":350.0,"shares_display":"350","price_per_share":12.89,"price_display":"12.89","price_state":"stated","total_value":4511.5,"total_display":"4,511.50","total_whole":"4,512","shares_owned_after":17130.0,"shares_owned_after_display":"17,130","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-21","filed_date":"2023-03-23","scope":"insider"},{"id":8553341,"accession":"0001841401-23-000002","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001841401-23-000002","line_url":"/filing/0001841401-23-000002#line-2","is_derivative":false,"issuer_cik":"0001819790","issuer_name":"Tarsus Pharmaceuticals, Inc.","issuer_ticker":"TARS","issuer_name_source":null,"issuer_url":"/issuer/0001819790","owner_cik":"0001841401","owner_name":"Wahl Bryan","owner_display_name":"Wahl Bryan","owner_url":"/insider/0001841401","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":357.0,"shares_display":"357","price_per_share":12.61,"price_display":"12.61","price_state":"stated","total_value":4501.77,"total_display":"4,501.77","total_whole":"4,502","shares_owned_after":17480.0,"shares_owned_after_display":"17,480","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-20","filed_date":"2023-03-21","scope":"insider"},{"id":8553335,"accession":"0001841401-23-000002","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001841401-23-000002","line_url":"/filing/0001841401-23-000002#line-1","is_derivative":false,"issuer_cik":"0001819790","issuer_name":"Tarsus Pharmaceuticals, Inc.","issuer_ticker":"TARS","issuer_name_source":null,"issuer_url":"/issuer/0001819790","owner_cik":"0001841401","owner_name":"Wahl Bryan","owner_display_name":"Wahl Bryan","owner_url":"/insider/0001841401","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":339.0,"shares_display":"339","price_per_share":13.28,"price_display":"13.28","price_state":"stated","total_value":4501.92,"total_display":"4,501.92","total_whole":"4,502","shares_owned_after":17837.0,"shares_owned_after_display":"17,837","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-17","filed_date":"2023-03-21","scope":"insider"},{"id":8035771,"accession":"0001209191-23-019884","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-019884","line_url":"/filing/0001209191-23-019884#line-2","is_derivative":false,"issuer_cik":"0001819790","issuer_name":"Tarsus Pharmaceuticals, Inc.","issuer_ticker":"TARS","issuer_name_source":null,"issuer_url":"/issuer/0001819790","owner_cik":"0001841401","owner_name":"Wahl Bryan","owner_display_name":"Wahl Bryan","owner_url":"/insider/0001841401","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":337.0,"shares_display":"337","price_per_share":13.43,"price_display":"13.43","price_state":"stated","total_value":4525.91,"total_display":"4,525.91","total_whole":"4,526","shares_owned_after":18176.0,"shares_owned_after_display":"18,176","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-16","filed_date":"2023-03-17","scope":"insider"},{"id":6410876,"accession":"0001841401-22-000006","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001841401-22-000006","line_url":"/filing/0001841401-22-000006#line-1","is_derivative":false,"issuer_cik":"0001819790","issuer_name":"Tarsus Pharmaceuticals, Inc.","issuer_ticker":"TARS","issuer_name_source":null,"issuer_url":"/issuer/0001819790","owner_cik":"0001841401","owner_name":"Wahl Bryan","owner_display_name":"Wahl Bryan","owner_url":"/insider/0001841401","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1154.0,"shares_display":"1,154","price_per_share":16.9,"price_display":"16.90","price_state":"stated","total_value":19502.6,"total_display":"19,502.60","total_whole":"19,503","shares_owned_after":13723.0,"shares_owned_after_display":"13,723","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-02","filed_date":"2022-12-06","scope":"insider"},{"id":6292488,"accession":"0001841401-22-000004","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001841401-22-000004","line_url":"/filing/0001841401-22-000004#line-3","is_derivative":false,"issuer_cik":"0001819790","issuer_name":"Tarsus Pharmaceuticals, Inc.","issuer_ticker":"TARS","issuer_name_source":null,"issuer_url":"/issuer/0001819790","owner_cik":"0001841401","owner_name":"Wahl Bryan","owner_display_name":"Wahl Bryan","owner_url":"/insider/0001841401","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1164.0,"shares_display":"1,164","price_per_share":16.75,"price_display":"16.75","price_state":"stated","total_value":19497.0,"total_display":"19,497.00","total_whole":"19,497","shares_owned_after":14877.0,"shares_owned_after_display":"14,877","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-01","filed_date":"2022-12-01","scope":"insider"},{"id":6292486,"accession":"0001841401-22-000004","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001841401-22-000004","line_url":"/filing/0001841401-22-000004#line-2","is_derivative":false,"issuer_cik":"0001819790","issuer_name":"Tarsus Pharmaceuticals, Inc.","issuer_ticker":"TARS","issuer_name_source":null,"issuer_url":"/issuer/0001819790","owner_cik":"0001841401","owner_name":"Wahl Bryan","owner_display_name":"Wahl Bryan","owner_url":"/insider/0001841401","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1183.0,"shares_display":"1,183","price_per_share":16.5,"price_display":"16.50","price_state":"stated","total_value":19519.5,"total_display":"19,519.50","total_whole":"19,520","shares_owned_after":16041.0,"shares_owned_after_display":"16,041","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-30","filed_date":"2022-12-01","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":17,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":17,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":17},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001819790","name":"Tarsus Pharmaceuticals, Inc.","url":"/issuer/0001819790","role":"Officer (General Counsel)","n_filings":9,"first_seen":"2022-12-01","last_seen":"2026-03-19"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001841401","retrieved_at":"2026-08-23T21:45:27+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}